Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats

European Journal of Nutrition

Volumn 56, Issue 1, 2017, Pages 133-150

  Wong, Weng Yew ^a,d   Ward, Leigh C ^a   Fong, Chee Wai ^b   Yap, Wei Ney ^b   Brown, Lindsay ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b DAVOS LIFE SCIENCE PTE LTD   (Singapore)

^c UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^d CENTENARY INSTITUTE   (Australia)

Author keywords

Anti inflammatory; Cardiovascular; Metabolic syndrome; Obesity; Tocopherols; Tocotrienols

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; COLLAGEN; DELTA TOCOTRIENOL; DRINKING WATER; FAT DROPLET; FATTY ACID; FRUCTOSE; GAMMA TOCOTRIENOL; GLUCOSE; POLYSACCHARIDE; STARCH; SUCROSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARBOHYDRATE DIET; TOCOTRIENOL, ALPHA; TOCOTRIENOL, DELTA;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEEF; CARBOHYDRATE INTAKE; CARDIOVASCULAR FUNCTION; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; ENDOCRINE FUNCTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART TISSUE; HYPERTENSION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAPERITONEAL FAT; ISOLATED HEART; LIPID STORAGE; LIVER FUNCTION; LIVER STRUCTURE; LIVER TISSUE; LIVER WEIGHT; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR REMODELING; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; BLOOD; BODY COMPOSITION; CARBOHYDRATE DIET; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; LIPID DIET; LIVER; METABOLISM; OBESITY, ABDOMINAL; ORGAN SIZE; WISTAR RAT;

ADIPOSE TISSUE; ALPHA-TOCOPHEROL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY COMPOSITION; CARDIOVASCULAR SYSTEM; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; FATTY LIVER; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; ORGAN SIZE; RATS; RATS, WISTAR; TOCOTRIENOLS; VITAMIN E;

EID: 84944551099     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-1064-1     Document Type: Article

References (72)

1. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428
2. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679–689
3. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 113:898–918
4. Tesauro M, Cardillo C (2011) Obesity, blood vessels and metabolic syndrome. Acta Physiol (Oxf) 203:279–286
5. Nikolopoulou A, Kadoglou NP (2012) Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther 10:933–939
6. Guerra F, Mancinelli L, Angelini L, Fortunati M, Rappelli A, Dessì-Fulgheri P, Sarzani R (2011) The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients. PLoS One 6:e16630
7. Nestel PJ, O’Brien R, Nelson M (2008) Management of dyslipidaemia—evidence and practical recommendations. Aust Fam Physician 37:521–527
8. Scarpellini E, Tack J (2012) Obesity and metabolic syndrome: an inflammatory condition. Dig Dis 30:148–153
9. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
10. Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, Gitto E, Arrigo T (2015) Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 16:378–400
11. Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437
12. National Heart Foundation of Australia. Factsheet: overweight and obesity statistics 2012
13. Health Survey of England. Adult anthropometric measures, overweight and obesity 2013
14. Khambalia AZ, Seen LS (2010) Trends in overweight and obese adults in Malaysia (1996–2009): a systematic review. Obes Rev 11:403–412
15. Weng-Yew W, Brown L (2011) Nutrapharmacology of tocotrienols for metabolic syndrome. Curr Pharm Des 17:2206–2214
16. Wong WY, Poudyal H, Ward LC, Brown L (2012) Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients 4:1527–1541
17. Traber MG, Atkinson J (2007) Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43:4–15
18. Yoshida Y, Niki E, Noguchi N (2003) Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 123:63–75
19. Aggarwal BB, Sundaram C, Prasad S, Kannappan R (2010) Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 80:1613–1631
20. Panchal SK, Poudyal H, Arumugam TV, Brown L (2011) Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr 141:1062–1069
21. Festing MFW, Altman DG (2002) Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43:244–258
22. National Research Council (1995) Nutrient requirements of laboratory animals, fourth revised edition, 1995. The National Academies Press, Washington
23. Nakamura H, Furukawa F, Nishikawa A, Miyauchi M, Son HY, Imazawa T, Hirose M (2001) Oral toxicity of a tocotrienol preparation in rats. Food Chem Toxicol 39:799–805
24. Brown L, Fenning A, Chan V, Loch D, Wilson K, Anderson B, Burstow D (2002) Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ 11:167–173
25. Ward LC, Battersby KJ (2009) Assessment of body composition of rats by bioimpedance spectroscopy validation against dual-energy X-ray absorptiometry. Scand J Lab Anim Sci 36:253–261
26. Jeyakumar SM, Vajreswari A, Giridharan NV (2006) Chronic dietary vitamin A supplementation regulates obesity in an obese mutant WNIN/Ob rat model. Obesity 14:52–59
27. Chan V, Hoey A, Brown L (2006) Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol 148:902–908
28. Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R (2007) Isolated heart perfusion according to Langendorff—still viable in the new millennium. J Pharmacol Toxicol Methods 55:113–126
29. Brown L, Duce B, Miric G, Sernia C (1999) Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol 10(Suppl 11):S143–S148
30. Sundram K, Nor R (2002) Analysis of tocotrienols in different sample matrixes by HPLC. In: Amstrong D (ed) Methods in molecular biology: oxidative stress biomarkers and antioxidant protocols. Humana Press Inc, Totowa, pp 221–232
31. Ueda T, Igarashi O (1987) New solvent system for extraction of tocopherols from biological specimens for HPLC determination and evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J Micronutr Anal 3:185–198
32. Traber MG, Frei B, Beckman JS (2008) Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr Opin Lipidol 19:30–38
33. Yang C, Suh N (2013) Cancer prevention by different forms of tocopherols. In: Pezzuto JM, Suh N (eds) Natural products in cancer prevention and therapy. Springer, Berlin, pp 21–33
34. Ahsan H, Ahad A, Iqbal J, Siddiqui WA (2014) Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond) 11:52
35. Kamal-Eldin A, Appelqvist L-Å (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31:671–701
36. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G (2010) Mechanisms of obesity-induced hypertension. Hypertens Res 33:386–393
37. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G (2010) Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 56:351–358
38. Dendorfer A, Raasch W, Tempel K, Dominiak P (1998) Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 93:24–29
39. Ishii H, Niioka T, Izumi H (2009) Circulating adrenaline released by sympathoadrenal activation elicits acute vasodilatation in the rat masseter muscle. Arch Oral Biol 54:486–494
40. Thackeray JT, Radziuk J, Harper ME, Suuronen EJ, Ascah KJ, Beanlands RS, Dasilva JN (2011) Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia. Cardiovasc Diabetol 10:75
41. Manzella D, Barbieri M, Ragno E, Paolisso G (2001) Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr 73:1052–1057
42. Nur Azlina MF, Nafeeza MI (2008) Tocotrienol and a-tocopherol reduce corticosterone and noradrenalin levels in rats exposed to restraint stress. Pharmazie 63:890–892
43. Anderson SL, Rubin BY (2005) Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia. Biochem Biophys Res Commun 336:150–156
44. Ima-Nirwana S, Suhaniza S (2004) Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J Med Food 7:45–51
45. Burdeos G, Nakagawa K, Kimura F, Miyazawa T (2012) Tocotrienol attenuates triglyceride accumulation in HepG2 Cells and F344 rats. Lipids 47:471–481
46. Uto-Kondo H, Ohmori R, Kiyose C, Kishimoto Y, Saito H, Igarashi O, Kondo K (2009) Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. J Nutr 139:51–57
47. Gee P (2010) Unleashing the untold and misunderstood observations on vitamin E. Genes Nutr 6:5–16
48. Ikeda I, Imasato Y, Sasaki E, Sugano M (1996) Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats. Int J Vitam Nutr Res 66:217–221
49. Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3–11
50. Shimizu T (2009) Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 49:123–150
51. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6:71–82
52. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176
53. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Hakkinen AM, Yki-Jarvinen H (2001) Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50:2337–2343
54. Steinberg HO, Baron AD (2002) Vascular function, insulin resistance and fatty acids. Diabetologia 45:623–634
55. Hayden MR, Sowers KM, Pulakat L, Joginpally T, Krueger B, Whaley-Connell A, Sowers JR (2011) Possible mechanisms of local tissue renin-angiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus. Cardiorenal Med 1:193–210
56. Suganami T, Tanaka M, Ogawa Y (2012) Adipose tissue inflammation and ectopic lipid accumulation. Endocr J 59:849–857
57. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
58. Zhao L, Kang I, Fang X, Wang W, Lee MA, Hollins RR, Marshall MR, Chung S (2015) Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment. Int J Obes (Lond) 39:438–446
59. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659–661
60. EFSA (2008) Opinion on mixed tocopherols, tocotrienol tocopherol and tocotrienols as sources for vitamin E added as a nutritional substance in food supplements. Scientific Opinion of the Panel on Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (Question No EFSA Q-2005-146, Q-2005-172, Q-2006-265) EFSA J 604:1–34
61. Tasaki M, Umemura T, Inoue T, Okamura T, Kuroiwa Y, Ishii Y, Maeda M, Hirose M, Nishikawa A (2008) Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year. Toxicology 250:143–150
62. Springett GM, Neuger AM, Centeno BA, Hutchinson T, Jump H, Lush R, Sebti S, Malafa MP (2011) Abstract 1299: a phase I dose-escalation study of the safety, PK, and PD of vitamin E delta-tocotrienol administered to subjects with resectable pancreatic exocrine neoplasia. Cancer Res 71:1299
63. Khosla P, Patel V, Whinter JM, Khanna S, Rakhkovskaya M, Roy S, Sen CK (2006) Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 8:1059–1068
64. Fairus S, Nor RM, Cheng HM, Sundram K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of alpha-tocopherol. Am J Clin Nutr 84:835–842
65. Fairus S, Nor RM, Cheng HM, Sundram K (2012) Alpha-tocotrienol is the most abundant tocotrienol isomer circulated in plasma and lipoproteins after postprandial tocotrienol-rich vitamin E supplementation. Nutr J 11:5
66. Yap SP, Yuen KH, Lim AB (2003) Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. J Pharm Pharmacol 55:53–58
67. Yap SP, Yuen KH, Wong JW (2001) Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53:67–71
68. Shibata A, Nakagawa K, Shirakawa H, Kobayashi T, Kawakami Y, Takashima R, Ohashi A, Sato S, Ohsaki Y, Kimura F, Kimura T, Tsuduki T, Komai M, Miyazawa T (2012) Physiological effects and tissue distribution from large doses of tocotrienol in rats. Biosci Biotechnol Biochem 76:1805–1808
69. Uchida T, Abe C, Nomura S, Ichikawa T, Ikeda S (2012) Tissue distribution of alpha- and gamma-tocotrienol and gamma-tocopherol in rats and interference with their accumulation by alpha-tocopherol. Lipids 47:129–139
70. Yamashita K, Ikeda S, Iizuka Y, Ikeda I (2002) Effect of sesaminol on plasma and tissue alpha-tocopherol and alpha-tocotrienol concentrations in rats fed a vitamin E concentrate rich in tocotrienols. Lipids 37:351–358
71. Frank J, Chin XW, Schrader C, Eckert GP, Rimbach G (2012) Do tocotrienols have potential as neuroprotective dietary factors? Ageing Res Rev 11:163–180
72. Hubbell RB, Mendel LB, Wakeman AJ (1937) A new salt mixture for use in experimental diets. J Nutr 14:273–285